Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection
Metabolism-Clinical and Experimental, 11/03/09
Wang Y–Y et al. – A BMI greater than or equal to 25 kg/m^2 and a fasting blood glucose level greater than or equal to 126 mg/dL were risk factors for increased ALT activity in subjects with hepatitis B infection, suggesting that obesity and diabetic fasting hyperglycemia may aggravate liver injury in this population.
Related Articles
Role of endothelial progenitor cells in diabetes mellitus
Expert Review of Endocrinology & Metabolism, 11/16/09
Relevance Score: 63%
Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study
Journal of Diabetes and its Complications, 10/12/09
Relevance Score: 46%
Exploring the complex care of the diabetic foot ulcer
JAAPA, 10/30/09
Relevance Score: 45%
Distribution and hydrolytic enzyme characteristics of Candida albicans strains isolated from diabetic patients and their non-diabetic consorts
Oral Microbiology and Immunology, 10/15/09
Relevance Score: 45%
Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09
Relevance Score: 45%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles
Journal of Viral Hepatitis, 11/25/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/25/09
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy
Journal of Viral Hepatitis, 11/25/09
Article Search
Sponsor


See Latest Articles


